QT
CLPT icon

Quantbot Technologies’s ClearPoint Neuro CLPT Stock Holding History

Quantbot Technologies’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.3K Buy
7,393
+5,819
+370% +$73.5K ﹤0.01% 1377
2025
Q4 		$21.5K Buy
+1,574
New +$29.2K ﹤0.01% 1564
2022
Q2 		– Sell
-500
Closed -$5K – 1746
2022
Q1 		$5K Buy
+500
New +$4.55K ﹤0.01% 1523

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Quantbot Technologies's CLPT Position: Q1 2026 in Review

Quantbot Technologies increased its ClearPoint Neuro (CLPT) stake by 370% in Q1 2026, buying an estimated $73.5K and bringing the position to 7,393 shares worth $67.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Quantbot Technologies first reported a position in CLPT in Q1 2022 and has held it in 3 quarters since. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Quantbot Technologies held 7,393 shares of ClearPoint Neuro worth $67.3K as of Q1 2026.
  • Quantbot Technologies bought 5,819 ClearPoint Neuro shares in Q1 2026, an estimated $73.5K.
  • ClearPoint Neuro made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1377 holding.
  • Quantbot Technologies first reported a position in ClearPoint Neuro in Q1 2022 and has held it in 3 quarters since.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.